FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileLiminatus Pharma, Inc. Warrants
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LIMNW
Liminatus Pharma, Inc. Warrants Stock AnalysisComprehensive stock analysis for Liminatus Pharma, Inc. Warrants (LIMNW) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisLIMNW
LIMNW
Liminatus Pharma, Inc. Warrants
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
LIMNW
  1. Home
  2. Stocks
  3. Liminatus Pharma, Inc. Warrants

Liminatus Pharma, Inc. Warrants

🇺🇸LIMNW•NASDAQ

Liminatus Pharma, Inc. Warrants

🇺🇸LIMNW•NASDAQ
Market cap
$1.00M

Your view on LIMNW

Mkt Cap
$1.00M
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Liminatus Pharma, Inc. Warrants

Industry
Biotechnology
Sector
Healthcare
CEO
Chris Kim
Headquarters
12611 Hiddencreek Way, Cerritos, CA, US
Industry
Biotechnology
Sector
Healthcare
CEO
Chris Kim
Headquarters
12611 Hiddencreek Way, Cerritos, CA, US
Description

Liminatus Pharma, Inc., situated in La Palma, California, is an immuno-oncology firm actively engaged in clinical trials, dedicated to pioneering innovative treatments for various cancers.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Liminatus Pharma, Inc. Warrants. Starting points for Liminatus Pharma, Inc. Warrants: EPS -$26.36, beta 0.74 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Liminatus Pharma, Inc. Warrants. Trailing twelve-month EPS for Liminatus Pharma, Inc. Warrants stands at -$26.36. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Liminatus Pharma, Inc. Warrants. Liminatus Pharma, Inc. Warrants has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold LIMNW12 companies
More Biotechnology companies
TickerTypeCompanySectorExchangeMkt cap
BICTFBiocure Technology Inc.HealthcareOTC$379,088
BIOABioAge Labs, Inc.HealthcareNASDAQ$161.1M
BIOAFBioasis Technologies Inc.HealthcareOTC$15,883
BIORQBiora Therapeutics, Inc.HealthcarePNK—
BIT.AXBiotron LimitedHealthcareASX—
BITRFBiotron LimitedHealthcareOTC$29.2M
BIVIBioVie Inc.HealthcareNASDAQ$8.6M
BIXTBioxytran, Inc.HealthcareOTC$3.6M
BLAB.CNBritannia Life Sciences Inc.HealthcareCNQ$13.0M
BLEGBranded Legacy IncHealthcareOTC$542,622
BLRXBioLineRx Ltd.HealthcareNASDAQ$4.8M
BLSMBlossomHill Therapeutics, Inc.HealthcareNASDAQ$422.0M
Ownership & News

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Liminatus Pharma, Inc. Warrants executives and directors. Shares of Liminatus Pharma, Inc. Warrants have traded between $0.07 and $0.07 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Liminatus Pharma, Inc. Warrants. Coverage tracks Liminatus Pharma, Inc. Warrants within Biotechnology (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Liminatus Pharma, Inc. Warrants.

LIMNW AnalysisWeak
Past
1
Growth
2
Health
2
Profit
1
Value
1